Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis by Diaz, Jose A. et al.
Video Article
Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
Jose A. Diaz1, Shirley K. Wrobleski 1, Angela E. Hawley1, Benedict R. Lucchesi2, Thomas W. Wakefield1, Daniel D. Myers, Jr.1
1Conrad Jobst Vascular Research Laboratories, Section of Vascular Surgery, University of Michigan
2Department of Pharmacology, University of Michigan
Correspondence to: Jose A. Diaz at josediaz@med.umich.edu
URL: http://www.jove.com/details.php?id=2737
DOI: 10.3791/2737
Citation: Diaz J.A., Wrobleski  S.K., Hawley A.E., Lucchesi B.R., Wakefield T.W., Myers, Jr. D.D. (2011). Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis. JoVE. 53.
http://www.jove.com/details.php?id=2737, doi: 10.3791/2737
Abstract
Animal models serve a vital role in deep venous thrombosis (DVT) research in order to study thrombus formation, thrombus resolution and to test
potential therapeutic compounds (1). New compounds to be utilized in the treatment and prevention of DVT are currently being developed. The
delivery of potential therapeutic antagonist compounds to an affected thrombosed vein has been problematic. In the context of therapeutic
applications, a model that uses partial stasis and consistently generates thrombi within a major vein has been recently established. The
Electrolytic Inferior vena cava Model (EIM) is mouse model of DVT that permits thrombus formation in the presence of continuous blood flow. This
model allows therapeutic agents to be in contact with the thrombus in a dynamic fashion, and is more sensitive than other models of DVT (1). In
addition, this thrombosis model closely simulates clinical situations of thrombus formation and is ideal to study venous endothelial cell activation,
leukocyte migration, venous thrombogenesis, and to test therapeutic applications (1). The EIM model is technically simple, easily reproducible,
creates consistent thrombi sizes and allows for a large sample (i.e. thrombus and vein wall) which is required for analytical purposes.
Protocol
1. Mouse Anesthesia Procedures
2. Mouse Micro-surgical and Recovery Procedures
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1. Animals are removed from their cage and placed in an anesthetic pre-operative induction chamber for gas induction at 2% isoflurane and
100% oxygen at a flow rate of 0.5 liters per minute (vaporizer controlled).
2. Mice are sedated in the anesthetic induction chamber, removed from chamber and the ventral abdomen is shaved with electric clippers, or
maintained within the chamber if a hair depilatory is used (1 min).
3. While still under sedation, they are weighed, the eyes are lubricated with sterile opthalmic ointment and, then placed in dorsal recumbancy on
a warm water circulating heating device under general anesthesia with a nose cone using isoflurane and oxygen. At this point the oxygen rate
is reduced to 0.2 liters per minute.
4. The abdomen is sprayed with chlorhexidine solution (chlorhexidine diacetate is rapidly bacterialcidal and persistent) and wiped with sterile
gauze three times or until the surgical site is clean.
1. A ventral midline incision (2 cm) is made with iris scissors through the skin and abdominal wall exposing the abdomen. A sterile saline soaked
2x2 in gauze is used to reflect the intestines to the animal's left side. A mouse restrainer is put in place allowing visualization of the inferior
vena cava (IVC).
2. At this point, the isoflurane is reduced to a maintenance level of 2% and the oxygen rate remains at 0.2 liters per minute for the remainder of
the surgical procedure.
3. Blunt dissection is facilitated using a sterile applicator swab and extra delicate iris half curved tissue forceps. Care must be taken in handling
mouse tissues for they are extremely fragile.
4. All IVC side branches, from the renal veins to the iliac bifurcation, are ligated with 7-0 non-reactive prolene sutures. Back branches remained
patent.
5. In the electrolytic IVC model (EIM), a 25G stainless-steel needle, attached to a silver coated copper wire (KY-30-1-GRN, Electrospec, Dover,
NJ) is inserted into the exposed caudal IVC, (Figure 1) and positioned against the anterior wall (anode).
6. Another wire is implanted subcutaneously completing the circuit (cathode).
7. A current of 250 μAmps over 15 minutes was applied using a Grass S48 square wave stimulator and a constant current unit (Grass
Technologies, An Astro-Med, Inc.,West Warwick, RI). The direct current results in the formation of toxic products of electrolysis that erode the
endothelial surface of the IVC promoting a thrombogenic environment and subsequent thrombus formation.
8. After 15 minutes, the needle is removed and a cotton swab is held gently in contact with the area to prevent bleeding
9. In sham animals, the needle is placed into the IVC and then removed, without application of the current.
10. The laparotomy site is closed in a two-layer fashion. Our laboratory uses 5-0 vicryl, a synthetic suture, in a continuous pattern to close the
abdominal wall. Adhesive skin glue is used to close the skin. There are no external sutures for removal.
11. Mice are then recovered in an individual mouse cage, closely observed post-operatively (45 minutes to 2 hours) under a heating lamp (min
distance 24 inches away from cage), then returned to their original housing units. Pain medication and anti-inflammatory agents can be used
if it does not interfere with study objective. Scientific justification to withhold pain medications, veterinary, and ICUCA approval are needed.
Our laboratory has found that Buprenorphine,0.05-0.1 mg/kg SQ is an excellent pre- and post-operative analgesic for mice. In addition,
Lidocaine at 4mg/kg (0.4 ml/kg of a 1% solution) can be infused in the incision site when systemic analgesics may confound experimental
results.
12. We typically do not experience post-operative adverse effects due to DVT. However, adverse post- operative effects can include spontaneous
anesthetic death, surgical blood loss, and partial paresis due to nerve trauma. Animals that are slow to recover can be fed nutria gel or have3. Representative Results
The EIM is a model that forms thrombus in the presence of continuous blood flow. The following figures show parameters investigated in this
novel model.
Figure 1 definesthe anatomical area in where a 25G stainless-steel needle, attached to a silver coated copper wire (KY-30-1-GRN, Electrospec,
Dover, NJ) is inserted. Note that a lymphatic node is almost present and helps as a landmark to find the caudal IVC.
Figure 2: Thrombus weight 2 days after EIM in different strains. As expected, thrombus weight was lower in PAI-1 KO mice and larger in
hypercoagulable Delta CT mice (^CT).
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moist chow placed on the floor of the cage to facilitate the animal's recovery. Animals with sever post- operative complications should be
humanely euthanized.
13. At the assigned time point, euthanasia is performed humanely in accordance with the recommendations set forth by the American Veterinary
Medical Association Guidelines on Euthanasia for rodents.Figure 3: Soluble P-selectin, a maker for deep vein thrombosis, was measured in different strains. The lowest levels were found in PAI-1 KO
mice whereas the highest levels were found in hypercoagulable delta CT mice.
Figure 4 Correlation between thrombus weight and soluble P-selectin was found in different strains. Of note, in the group that generated the
shorter thrombus size, the soluble P-selectin detected was the lowest (PAI-1 KO mice). In the group that generated the largest thrombus size, the
soluble P-selectin detected was the highest (hypercoagulable delta CT).
Figure 5: In order to demonstrate presence of blood flow, ultrasound was performed in mice undergoing EIM. Figure 5 shows the ultrasound
performed in a mouse 2 days after EIM. Then the specimen was harvest. Note the that the thrombus shape suggest thrombus formation in
presence of flow
Discussion
The mouse is an excellent research tool for in vivo experiments. Thus, the development of mouse models that closely mimic diseases or
pathological conditions are necessary. Several venous thrombosis mouse models have been used to study DVT including: photochemical (2),
stasis (3-4) and mechanical trauma (5-6). However, none of these models use an internal endothelial stimulus to generate thrombus in the
presence of continuous blood flow. The EIM, using electrolytic stimulus within the IVC, promotes venous thrombogenesis by endothelial activation
in the presence of blood flow (1). It is technically simple, easily reproducible and has a high survival rate (99%). Despite the fact that an electrical
current is used to create the electrolysis, heat is not generated (1). The EIM model closely simulates clinical DVT, and therefore serves as a
valuable tool for studying the intrinsic mechanisms of thrombus formation and resolution. The EIM model is also useful for the advancement of
new therapeutic approaches against thrombosis disease.
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